Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eyenovia Inc (EYEN)
NASDAQ:EYEN
Holding EYEN?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.09Last Year’s EPS
-$0.18Same Quarter Last Year
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2024
|% Change Since: -81.60%
|Next Earnings Date:Mar 26, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with significant advances in product development and strategic partnerships but was overshadowed by financial challenges and a need for further capital. The company is making strong progress in product launches and regulatory approvals but faces ongoing financial hurdles that need addressing.Company Guidance
During the Eyenovia third-quarter 2024 earnings call, the company provided significant guidance and updates on their strategic developments. Michael Rowe, the CEO, highlighted the nearing Phase III efficacy data readout for MicroPine, a product targeting pediatric progressive myopia, and the potential to access a multibillion-dollar market. Eyenovia is also advancing its next-generation Optejet technology, expected to enhance their profitability profile. The company is commercializing MydCombi and clobetasol, with the latter already placed in over 100 pharmacies. The CEO discussed the potential for the MicroPine NDA submission as soon as early 2026 if the ongoing Phase III CHAPERONE study yields positive results. Furthermore, the Gen 2 Optejet device could provide margins of up to 90%. Eyenovia's partnerships with Formosa, Senju, and SGN to address unmet needs in the dry eye market were also emphasized, alongside a licensing program with Arctic Vision in China and South Korea, potentially bringing in $37 million in future milestones. The company reported a net loss of $7.9 million for the quarter, with unrestricted cash at $7.2 million, reflecting ongoing strategic investments and commercialization efforts.Significant Progress in MicroPine Development
Eyenovia is approaching a Phase III efficacy data readout for MicroPine, targeting a multibillion-dollar market for pediatric progressive myopia.
Launch of Clobetasol
Eyenovia launched clobetasol, an FDA-approved ophthalmic steroid, seeing strong interest and distribution in over 100 offices.
Expansion of MydCombi
MydCombi, based on Optejet technology, is now used in over 200 ophthalmology offices, with plans to expand to 200 more offices.
Strategic Partnerships and Collaborations
Established development collaborations with Formosa, Senju, and SGN for dry eye disease treatments leveraging Optejet technology.
Manufacturing and Regulatory Progress
Successful audits by the Nevada Board of Pharmacy and FDA, enabling manufacturing and distribution from the Reno facility.
---
EYEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EYEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $0.50 | $0.41 | -18.00% |
| Aug 12, 2024 | $0.88 | $0.80 | -9.09% |
| May 15, 2024 | $1.06 | $0.82 | -22.64% |
| Mar 18, 2024 | $1.53 | $1.18 | -22.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Eyenovia Inc (EYEN) report earnings?
Eyenovia Inc (EYEN) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Eyenovia Inc (EYEN) earnings time?
Eyenovia Inc (EYEN) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EYEN EPS forecast?
EYEN EPS forecast for the fiscal quarter 2024 (Q4) is -$0.09.
---